Laura Saracino
Veneto, Italia
546 follower
Oltre 500 collegamenti
Visualizza i collegamenti in comune con Laura
Piacere di rivederti
Cliccando su “Continua” per iscriverti o accedere, accetti il Contratto di licenza, l’Informativa sulla privacy e l’Informativa sui cookie di LinkedIn.
Nuovo utente di LinkedIn? Iscriviti ora
oppure
Cliccando su “Continua” per iscriverti o accedere, accetti il Contratto di licenza, l’Informativa sulla privacy e l’Informativa sui cookie di LinkedIn.
Nuovo utente di LinkedIn? Iscriviti ora
Visualizza i collegamenti in comune con Laura
Piacere di rivederti
Cliccando su “Continua” per iscriverti o accedere, accetti il Contratto di licenza, l’Informativa sulla privacy e l’Informativa sui cookie di LinkedIn.
Nuovo utente di LinkedIn? Iscriviti ora
oppure
Cliccando su “Continua” per iscriverti o accedere, accetti il Contratto di licenza, l’Informativa sulla privacy e l’Informativa sui cookie di LinkedIn.
Nuovo utente di LinkedIn? Iscriviti ora
Esperienza
Visualizza il profilo completo di Laura
Altri profili simili
-
Mario Sacchi
PaviaCollegati -
Chiara Campo, PhD
MilanoCollegati -
Cristina Violi
ParmaCollegati -
Ana Petrovic
Senior Project Manager
Venezia MestreCollegati -
Stefania Lamartina
RomaCollegati -
Mauro Bazzigaluppi
Clinical Trial Lead at PSI CRO AG
GenovaCollegati -
Alessandra Denaro
Clinical Research Manager presso Novo Nordisk
SalernoCollegati -
Laura Chiesa
VillasantaCollegati -
Alessia La Palombara
Associate Clinical Project Management Director at IQVIA
MilanoCollegati -
Ilaria Albieri
Clinical Project Manager at Takeda Pharmaceuticals
ZurigoCollegati -
Sara Projetto
Sr. Clinical Project Manager, Real World Solution at IQVIA
MilanoCollegati -
Alessandro Ruggieri
Clinical Researcher, Clinical Study Manager
RomaCollegati -
Maria Paola Contini
MagonzaCollegati -
Barbara Saccon
Clinical Project Manager at Italfarmaco SpA
MilanoCollegati -
Sofia Carcano
MilanoCollegati -
Michela Muzzi
RomaCollegati -
Paola Marighetti, PhD
MilanoCollegati -
Giulia Zotti
MilanoCollegati -
Simona Pegorini
MilanoCollegati -
Elisabetta Bonfanti
MilanoCollegati
Esplora altri post
-
Health365info.com
Modifications of the readiness assessment for pragmatic trials tool for appropriate use with Indigenous populations https://lnkd.in/dNmAArD4 Inequities in health access and outcomes exist between Indigenous and non-Indigenous populations. Embedded pragmatic randomized, controlled trials (ePCTs) can test the real-world effectiveness of health care i...
-
es/iode
📃Scientific paper: Absence of association between 2019‐20 influenza vaccination and COVID‐19: Results of the European I‐MOVE‐COVID‐19 primary care project, March‐August 2020 Abstract: International audience; Background: Claims of influenza vaccination increasing COVID-19 risk are circulating. Within the I-MOVE-COVID-19 primary care multicentre study, we measured the association between 2019-20 influenza vaccination and COVID-19. Methods: We conducted a multicentre test-negative case-control study at primary care level, in study sites in five European countries, from March to August 2020. Patients presenting with acute respiratory infection were swabbed, with demographic, 2019-20 influenza vaccination and clinical information documented. Using logistic regression, we measured the adjusted odds ratio (aOR), adjusting for study site and age, sex, calendar time, presence of chronic conditions. The main analysis included patients swabbed ≤7 days after onset from the three countries with <15% of missing influenza vaccination. In secondary analyses, we included five countries, using multiple imputation with chained equations to account for missing data.Results: We included 257 COVID-19 cases and 1631 controls in the main analysis (three countries). The overall aOR between influenza vaccination and COVID-19 was 0.93 (95% CI: 0.66-1.32). The aOR was 0.92 (95% CI: 0.58-1.46) and 0.92 (95% CI: 0.51-1.67) among those aged 20-59 and ≥60 years, respectively. In secondary analyses, we included 6457 cases and 69 272 controls. The imputed aOR was 0.87 (95% CI: 0.79-0.95) among all ages and any delay between swab and symptom onset.Conclusions: Ther... Continued on ES/IODE ➡️ https://etcse.fr/xLz9 ------- If you find this interesting, feel free to follow, comment and share. We need your help to enhance our visibility, so that our platform continues to serve you.
-
Publishers Learning And Community Exchange (PLACE)
COPE has released a new flowchart to guide editors through the process of handling submissions that have been submitted elsewhere at the same time. It includes actions to take and who to contact. Read more and download the flowchart on the COPE website: https://lnkd.in/edZ_hHXa #researchintegrity #publicationethics
2 -
es/iode
📃Scientific paper: HealthMap: a cluster randomised trial of interactive health plans and self-management support to prevent coronary heart disease in people with HIV Abstract: BACKGROUND: The leading causes of morbidity and mortality for people in high-income countries living with HIV are now non-AIDS malignancies, cardiovascular disease and other non-communicable diseases associated with ageing. This protocol describes the trial of HealthMap, a model of care for people with HIV (PWHIV) that includes use of an interactive shared health record and self-management support. The aims of the HealthMap trial are to evaluate engagement of PWHIV and healthcare providers with the model, and its effectiveness for reducing coronary heart disease risk, enhancing self-management, and improving mental health and quality of life of PWHIV. METHODS/DESIGN: The study is a two-arm cluster randomised trial involving HIV clinical sites in several states in Australia. Doctors will be randomised to the HealthMap model (immediate arm) or to proceed with usual care (deferred arm). People with HIV whose doctors are randomised to the immediate arm receive 1) new opportunities to discuss their health status and goals with their HIV doctor using a HealthMap shared health record; 2) access to their own health record from home; 3) access to health coaching delivered by telephone and online; and 4) access to a peer moderated online group chat programme. Data will be collected from participating PWHIV (n = 710) at baseline, 6 months, and 12 months and from participating doctors (n = 60) at baseline and 12 months. The control arm will be offered the HealthMap intervention ... Continued on ES/IODE ➡️ https://etcse.fr/lzRy1 ------- If you find this interesting, feel free to follow, comment and share. We need your help to enhance our visibility, so that our platform continues to serve you.
-
Vaccines Europe
In the EU/EEA region, antimicrobial resistance #AMR poses a health burden comparable to influenza, TB & HIV/AIDS combined. Vaccination is a valuable asset in our fight against this growing health threat. Learn more: https://bit.ly/3sAauh0 #WorldImmunisationWeek #WIW #EIW
73 -
European Liver Patients' Association - ELPA
📢 Urgent Alert: Rising Steatotic Liver Disease in Children and Adolescents 🧒👦 #FattyLiverMonth #FattyLiverDay Yiannoula Koulla, Leader of the ELPA SLD Working Group and President of the Cyprus Liver Patients Association, sounds the alarm on the growing threat of Steatotic (Fatty) Liver Disease worldwide. This condition, if left unchecked, can lead to severe health issues. 🔍 Early Detection is Key:The disease is increasingly being diagnosed in children and adolescents. With early and appropriate treatment, liver damage can be reversible. 👩⚕️👨⚕️ Our Call to Action: We must implement holistic treatment strategies and start with our youngest. It's crucial to conduct screenings for children at risk. By doing so, we give them the chance to a healthier future. Let's act NOW to protect our children's health. Screen early, treat early, and reverse the trend. 💪🌍 #LiverHealth #SLD #ChildHealth #EarlyDetection #ELPA #HolisticTreatment EASL the home of Hepatology UEG - United European Gastroenterology ESMO - European Society for Medical Oncology International Liver Cancer Association (ILCA) EU Health and Food Safety WHO Regional Office for Europe Marko Korenjak MSc Milan Mishkovikj, M.A. Veronika Všetíčková
13 -
British Institutes Seregno - Language Club
A word a day keeps your brain trained! 🧠 La parola di oggi è #HOOD: a device above a cooker that consists of a cover with anextractor fan (= a piece of equipment for removing steam, smoke, or unpleasant smells) inside. #WordOfTheDay #LearnEnglish #EnglishVocabulary #EnglishTip
-
Research and Training for Health and Development (RTHD)
The declaration of the mpox outbreak as a public health emergency of international concern (PHEIC) signifies intensified international co-ordination, evidence -based action and advancement of vaccine development. In a review article by Wilder-Smith and Osman(2020), the rationale and application of the PHEIC is described ( Journal of Travel Medicine, 2020, 1–13 doi: 10.1093/jtm/taaa227) #epidemiccontrol #healthequity https://lnkd.in/dN45XXQM
31 commento -
International Journal of Gynecology & Obstetrics
Implementation of Maternal and Perinatal Death Surveillance and Review can reduce mortality but its implementation is often suboptimal, especially in low- and middle-income countries. Read this #OA systematic review to explore how MPDSR could be improved: https://lnkd.in/eXu5w_Jv
31 commento -
Cochrane Nigeria
This review aims to assess strategies to increase the number of children vaccinated in low - and middle-income countries. 41 studies covering 100,747 participants from 20 countries were included. The main findings indicate that: - Immunisation outreach and health education likely improve vaccination rates. - Specially designed immunisation cards and community leader involvement may have a positive impact. - Phone reminders may have little effect. - The evidence's certainty ranges from moderate to very low, suggesting that further research is needed. The review highlights the need for more rigorous research to inform policy and practice in increasing vaccine uptake in low- and middle-income countries. Authors: Oyo-Ita A, Oduwole O, Arikpo D, Effa EE, Esu EB, Balakrishna Y, Chibuzor MT, Oringanje CM, Nwachukwu CE, Wiysonge CS, Meremikwu MM Link: https://lnkd.in/g_fGzHcg
15 -
Center for Outbreak Response Innovation (CORI)
📅 Tune into your weekly CORI disease forecast: The percentage of positive COVID tests is declining, although it remains the highest it has been in 2.5 years. This trend corresponds with a decrease in emergency department visits for COVID. #PublicHealth #HealthSecurity #GlobalHealth #Epidemiology #ReadMore
1 -
IPQ Academy
The WHO #Global #tuberculosis report 2024 provides a #comprehensive and up-to-date assessment of the TB epidemic and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
81 commento -
Rivers State Ministry of Health
#LassaFever Situation Update in Rivers State (15/04/2024) Total Suspected Cases: 59 Laboratory Confirmed Positive Cases: 6 (2 Postmortem) Treated and Discharged Positive Cases: 4 Laboratory Confirmed Negative Cases: 52 Contacts of Cases under Follow-up: 0 Contacts who have Exited Surveillance: 148 Laboratory Pending Sample Result: 1 Remember, #Lassafever is preventable. Protect yourself and your loved ones and stay informed about how the Lassa virus spreads and its common symptoms! #Health4AllRivers #lassafeverawareness #StaySafeStayHealthy
3 -
The Trinity Challenge
Today, on #WorldImmunisationDay, let's celebrate the power of vaccines in saving lives and preventing diseases. Let's also remember their crucial role in mitigating #AntimicrobialResistance by reducing the need for antibiotics in the first place, thereby preserving #antibiotic effectiveness. Let's protect our health and the future of antibiotics! 💉🌍 #AntibioticEmergency
61 commento -
EuFMD
How can Prequalification of vaccines (#PQvaccines or PQv) be used to maximize vaccine security for #FMD vaccines? 🔸 It offers an independent system for reliance assurance which improves confidence in vaccines. 🔸 Assist risk managers to access reliable information on vaccines that meet at least minimal international standards. 🔸 Assist countries with weak or inexperienced regulatory authorities to approve FMD vaccines More information➡️ https://lnkd.in/dCgeQEkj #FootandMouth #FMD #AnimalHealth #CapacityDevelopment
6
Altre persone che si chiamano Laura Saracino in Italia
-
Laura Saracino
Laureata in Economia aziendale
Verona -
Laura Saracino
operatrice accoglienza presso casa delle donne
Bologna -
Laura Saracino
Professional Counselor, Arteterapia, stereotipi e violenza di genere, formatrice, percorsi individuali e di gruppo sulla consapevolezza, empoderamiento, teambuilding, gestione delle emozioni per neomaggiorenni e adulti
Bologna -
Laura Emanuela Saracino
Export Quality Manager
Italia
Su LinkedIn ci sono altre 17 persone che si chiamano Laura Saracino in Italia
Vedi altre persone che si chiamano Laura Saracino